0001179110-20-010869.txt : 20201106 0001179110-20-010869.hdr.sgml : 20201106 20201106163036 ACCESSION NUMBER: 0001179110-20-010869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201104 FILED AS OF DATE: 20201106 DATE AS OF CHANGE: 20201106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobson Allan Steven CENTRAL INDEX KEY: 0001579003 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 201294859 MAIL ADDRESS: STREET 1: PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 edgar.xml FORM 4 - X0306 4 2020-11-04 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001579003 Jacobson Allan Steven C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 1 0 0 0 Common Stock 2020-11-04 4 M 0 20000 10.85 A 23498 D Common Stock 2020-11-04 4 S 0 20000 60.00 D 3498 D Stock Option (Right To Buy) 10.85 2020-11-04 4 M 0 20000 10.85 D 2023-05-15 Common Stock 20000 23000 D Stock Option (Right To Buy) 490.8 2021-04-27 Common Stock 250.0 250 D Stock Option (Right To Buy) 218.4 2022-01-10 Common Stock 83.0 83 D Stock Option (Right To Buy) 27.05 2024-01-27 Common Stock 10000.0 10000 D Stock Option (Right To Buy) 51.0 2025-01-01 Common Stock 12000.0 12000 D Stock Option (Right To Buy) 30.86 2026-01-03 Common Stock 12000.0 12000 D Stock Option (Right To Buy) 11.23 2027-01-02 Common Stock 12000.0 12000 D Stock Option (Right To Buy) 18.01 2028-01-02 Common Stock 14000.0 14000 D Stock Option (Right To Buy) 33.02 2029-01-21 Common Stock 14000.0 14000 D Stock Option (Right To Buy) 51.16 2030-01-28 Common Stock 10000.0 10000 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2020. Currently exercisable. This option was granted on January 29, 2020 and vests over one year in twelve equal monthly installments, commencing on February 29, 2020. /s/ Avraham S. Adler, attorney-in-fact 2020-11-06